{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:07:49Z","timestamp":1790190469378,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      ROSAH syndrome is a rare autosomal dominant disorder caused by heterozygous missense mutations in the\n                      <jats:italic>ALPK1<\/jats:italic>\n                      gene. It is clinically characterized by a spectrum of manifestations, including retinal dystrophy, optic disc edema, splenomegaly, anhidrosis, and headaches. This study performed an integrated evaluation of clinical manifestations, genetic alterations, and immunological profiles in a pediatric ROSAH syndrome case harboring an\n                      <jats:italic>ALPK1<\/jats:italic>\n                      mutation, with the objective of dissecting its putative immune-mediated pathogenesis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A 12-year-old male with unexplained splenomegaly and multisystem symptoms underwent clinical evaluation. Whole-exome and Sanger sequencing were used to identify\n                      <jats:italic>ALPK1<\/jats:italic>\n                      variants. Western blotting was applied to assess the activation status of the NF-\u03baB pathway in peripheral blood mononuclear cells (PBMCs), coupled with flow cytometric characterization of T- and B-lymphocyte subset distributions. Clinical manifestations and treatment of ROSAH Syndrome caused by\n                      <jats:italic>ALPK1<\/jats:italic>\n                      mutations were summarized by literature review.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The individual presented with progressive visual loss, anhidrosis, migraine, and arthralgia. A heterozygous\n                      <jats:italic>de novo ALPK1<\/jats:italic>\n                      variant (c.710C&amp;gt;T, p.Thr237Met) was identified. Elevated phosphorylated IKK\u03b2 levels indicated NF-\u03baB pathway activation. Lymphocyte profiling demonstrated markedly diminished CD3\n                      <jats:sup>+<\/jats:sup>\n                      and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell counts, with the CD4\n                      <jats:sup>+<\/jats:sup>\n                      \/CD8\n                      <jats:sup>+<\/jats:sup>\n                      ratio escalating to 2.61, concurrently with elevated proportions of activated CD4\n                      <jats:sup>+<\/jats:sup>\n                      , CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, and regulatory T-cell populations. B-cell lineage anomalies featured expansions in transitional B-cell subsets and plasmablasts, paralleled by reduced serum immunoglobulin concentrations. Approximately 70 cases have been reported globally, linked to four\n                      <jats:italic>ALPK1<\/jats:italic>\n                      mutations (c.710C&amp;gt;T, c.761A&amp;gt;G, c.830C&amp;gt;T, c.476C&amp;gt;T). Key clinical features include severe ocular involvement (retinal degeneration, optic nerve edema) and systemic manifestations such as splenomegaly and anhidrosis. Current management focuses on anti-inflammatory therapy and symptomatic support, while retinal degeneration remains untreatable.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      This case links a\n                      <jats:italic>de novo ALPK1<\/jats:italic>\n                      mutation to constitutive NF-\u03baB activation and immune dysfunction in ROSAH syndrome. Early genetic and immunological screening is essential for diagnosis and management of ROSAH syndrome. Targeted immunotherapy may alleviate symptoms, but further research is needed to define standardized approaches for this rare disorder.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1622079","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:24:13Z","timestamp":1761726253000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune function analysis in a pediatric patient with a de novo ALPK1 gene mutation"],"prefix":"10.3389","volume":"16","author":[{"given":"Xue","family":"Chuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuochen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212515","article-title":"Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study","volume":"77","author":"Ben-Chetrit","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.03.016","article-title":"Monogenic autoinflammatory diseases: concept and clinical manifestations","volume":"147","author":"Almeida de Jesus","year":"2013","journal-title":"Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.017","article-title":"Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach","volume":"146","author":"Nigrovic","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2024.1337329","article-title":"Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases","volume":"4","author":"Fonollosa","year":"2024","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(22)00360-5","article-title":"ROSAH syndrome: childhood-onset arthritis, hand deformities, uveitis, and splenomegaly","volume":"5","author":"Lequain","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2024.10.008","article-title":"Diseases caused by altered specificity of a protein kinase for its allosteric activators","volume":"50","author":"Cohen","year":"2025","journal-title":"Trends Biochem Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0433-3","article-title":"Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose","volume":"561","author":"Zhou","year":"2018","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2318794121","article-title":"TIFAB regulates the TIFA-TRAF6 signaling pathway involved in innate immunity by forming a heterodimer complex with TIFA","volume":"121","author":"Nakamura","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20220401","article-title":"Co-ordinated control of the ADP-heptose\/ALPK1 signalling network by the E3 ligases TRAF6, TRAF2\/c-IAP1 and LUBAC","volume":"479","author":"Snelling","year":"2022","journal-title":"Biochem J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222629","article-title":"Gain-of-function mutations in ALPK1 cause an NF-\u03baB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome","volume":"81","author":"Kozycki","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.12376\/j.issn.2097-0501.2022.03.010","article-title":"Multidisciplinary treatment on a case of ROSAH syndrome","volume":"1","author":"Zhong","year":"2022","journal-title":"J Rare Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"240260","DOI":"10.1098\/rsob.240260","article-title":"Discovery and functional analysis of a novel ALPK1 variant in ROSAH syndrome","volume":"14","author":"Snelling","year":"2024","journal-title":"Open Biol"},{"key":"B15","article-title":"ALPK1-related autoinflammatory disease","volume-title":"GeneReviews(\u00ae)","author":"Kozycki","year":"1993"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.3390\/cancers14184390","article-title":"Systematic review of the role of alpha-protein kinase 1 in cancer and cancer-related inflammatory diseases","volume":"14","author":"Ko","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-019-0421-6","article-title":"Rare missense variants in the ALPK1 gene may predispose to periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome","volume":"27","author":"Sangiorgi","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2152","article-title":"Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study","volume":"35","author":"Yamada","year":"2015","journal-title":"Int J Mol Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/s41467-019-09979-0","article-title":"ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma","volume":"10","author":"Rashid","year":"2019","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2313148120","article-title":"ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nucleotide sugars","volume":"120","author":"Snelling","year":"2023","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"004989","DOI":"10.12890\/2025_004989","article-title":"Hyperinflammation and blindness. Screening for ROSAH syndrome","volume":"12","author":"Tornero-Romero","year":"2025","journal-title":"Eur J Case Rep Intern Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/13816810.2025.2474024","article-title":"ROSAH syndrome presenting with recurrent vitreous hemorrhage: a multimodal imaging study","volume":"46","author":"Hong","year":"2025","journal-title":"Ophthalmic Genet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2025.1535805","article-title":"Case Report: ROSAH syndrome presents diagnostic and therapeutic challenges","volume":"5","author":"Shunyakova","year":"2025","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.34437","article-title":"An inherited disorder with splenomegaly, cytopenias, and vision loss","author":"Tantravahi","year":"2012","journal-title":"Am J Med Genet A"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01214-8","article-title":"Early onset of TNF\u03b1-driven arthritis, auto-inflammation, and progressive loss of vision in a patient with ALPK1 mutation","volume":"42","author":"Hecker","year":"2022","journal-title":"J Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000815","article-title":"The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: an update","volume":"33","author":"Chen","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12974-023-02808-8","article-title":"Lactobacillus paracasei L9 affects disease progression in experimental autoimmune neuritis by regulating intestinal flora structure and arginine metabolism","volume":"20","author":"Meng","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12703\/r\/10-30","article-title":"Recent advances in understanding the Th1\/Th2 effector choice","volume":"10","author":"Butcher","year":"2021","journal-title":"Fac Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","article-title":"\u03b3\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6309219","DOI":"10.1155\/2016\/6309219","article-title":"Balancing inflammation: the link between Th17 and regulatory T cells","volume":"2016","author":"Diller","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2249.2011.04460.x","article-title":"Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sj\u00f6gren's syndrome: clinical implications and effects of B cell-targeted therapies","volume":"167","author":"Vossenk\u00e4mper","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"102627","DOI":"10.1016\/j.jaut.2021.102627","article-title":"Marginal zone B cells: From housekeeping function to autoimmunity","volume":"119","author":"Palm","year":"2021","journal-title":"J Autoimmun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e12920","DOI":"10.1111\/sji.12920","article-title":"Putative role of marginal zone B cells in pathophysiological processes","volume":"92","author":"Marinkovic","year":"2020","journal-title":"Scand J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09168451.2015.1056512","article-title":"Development and function of follicular helper T cells","volume":"80","author":"Ise","year":"2016","journal-title":"Biosci Biotechnol Biochem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641013","article-title":"Frontiers of autoantibodies in autoimmune disorders: crosstalk between Tfh\/Tfr and regulatory B cells","volume":"12","author":"Ding","year":"2021","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1038\/s41467-025-63731-5","article-title":"Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndrome","volume":"16","author":"Fan","year":"2025","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1622079\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:24:15Z","timestamp":1761726255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1622079\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2025.1622079"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1622079","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1622079"}}